000			02180 a2200553 4500
005			20250513133722.0
264		0	_c19980127
008			199801s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1998.16.1.41 _2doi
040			_aNLM _beng _cNLM
100	1		_aHagenbeek, A
245	0	0	_aMaintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cJan 1998
300			_a41-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aLymphoma, Non-Hodgkin _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Staging
650	0	4	_aNeoplasm, Residual
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aProspective Studies
650	0	4	_aRecombinant Proteins
650	0	4	_aRemission Induction
650	0	4	_aSurvival Analysis
650	0	4	_aVincristine _xadministration & dosage
700	1		_aCarde, P
700	1		_aMeerwaldt, J H
700	1		_aSomers, R
700	1		_aThomas, J
700	1		_aDe Bock, R
700	1		_aRaemaekers, J M
700	1		_avan Hoof, A
700	1		_aDe Wolf-Peeters, C
700	1		_avan Glabbeke, M
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 16 _gno. 1 _gp. 41-7
856	4	0	_uhttps://doi.org/10.1200/JCO.1998.16.1.41 _zAvailable from publisher's website
999			_c9410011 _d9410011